X-18604120-A-G

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001323289.2(CDKL5):​c.1196A>G​(p.Asn399Ser) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 23)

Consequence

CDKL5
NM_001323289.2 missense

Scores

5
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 4.04
Variant links:
Genes affected
CDKL5 (HGNC:11411): (cyclin dependent kinase like 5) This gene is a member of Ser/Thr protein kinase family and encodes a phosphorylated protein with protein kinase activity. Mutations in this gene have been associated with X-linked infantile spasm syndrome (ISSX), also known as X-linked West syndrome, and Rett syndrome (RTT). Alternate transcriptional splice variants have been characterized. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.15637594).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CDKL5NM_001323289.2 linkuse as main transcriptc.1196A>G p.Asn399Ser missense_variant 12/18 ENST00000623535.2 NP_001310218.1 O76039-2
CDKL5NM_001037343.2 linkuse as main transcriptc.1196A>G p.Asn399Ser missense_variant 13/22 NP_001032420.1 O76039-1
CDKL5NM_003159.3 linkuse as main transcriptc.1196A>G p.Asn399Ser missense_variant 12/21 NP_003150.1 O76039-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CDKL5ENST00000623535.2 linkuse as main transcriptc.1196A>G p.Asn399Ser missense_variant 12/181 NM_001323289.2 ENSP00000485244.1 O76039-2

Frequencies

GnomAD3 genomes
Cov.:
23
GnomAD4 exome
Cov.:
32
GnomAD4 genome
Cov.:
23

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Developmental and epileptic encephalopathy, 2;CN128785:Angelman syndrome-like Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpMay 26, 2021This variant is not present in population databases (ExAC no frequency). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CDKL5 protein function. This variant has not been reported in the literature in individuals with CDKL5-related conditions. This sequence change replaces asparagine with serine at codon 399 of the CDKL5 protein (p.Asn399Ser). The asparagine residue is highly conserved and there is a small physicochemical difference between asparagine and serine. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.071
BayesDel_addAF
Benign
-0.34
T
BayesDel_noAF
Benign
-0.73
CADD
Benign
15
DANN
Uncertain
0.98
DEOGEN2
Benign
0.031
T;T;.;T;.;.
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Uncertain
0.96
.;D;D;D;D;D
M_CAP
Uncertain
0.096
D
MetaRNN
Benign
0.16
T;T;T;T;T;T
MetaSVM
Benign
-0.88
T
MutationAssessor
Benign
0.67
N;.;.;N;.;N
PrimateAI
Uncertain
0.60
T
PROVEAN
Benign
-1.1
N;.;.;N;.;.
REVEL
Benign
0.10
Sift
Benign
0.14
T;.;.;T;.;.
Sift4G
Benign
0.26
T;.;.;T;T;T
Polyphen
0.13
B;.;.;B;.;.
Vest4
0.31
MutPred
0.27
Gain of glycosylation at N399 (P = 0.0589);Gain of glycosylation at N399 (P = 0.0589);Gain of glycosylation at N399 (P = 0.0589);Gain of glycosylation at N399 (P = 0.0589);Gain of glycosylation at N399 (P = 0.0589);Gain of glycosylation at N399 (P = 0.0589);
MVP
0.82
MPC
0.43
ClinPred
0.56
D
GERP RS
4.9
Varity_R
0.16
gMVP
0.14

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chrX-18622240; API